share_log

Anavex Life Sciences Q2 2024 GAAP EPS $(0.13) Misses $(0.11) Estimate, Cash and Equivalents of $139.4M

Benzinga ·  May 9 07:34

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 176.47 percent decrease over earnings of $0.17 per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment